HotSpot Therapeutics Appoints Niti Goel, M.D., as Chief Medical Officer
Seasoned drug development leader to drive clinical development of small molecule IRF5 inhibitor, HST-2011, nominated as Development Candidate for lupus and other autoimmune diseases BOSTON, Aug. 18, 2026 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the...
Covered in this story
What has happened since
- Host Hotels & Resorts is up 8.2% since this was published, 63 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $HST yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Host Hotels & Resorts →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.